177 related articles for article (PubMed ID: 35692595)
21. Épico Project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients.
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3):135-49. PubMed ID: 23727234
[TBL] [Abstract][Full Text] [Related]
22. [Mortality Risk Factors for Invasive Candidiasis in Pediatric Intensive Care Unit].
Korulmaz A; Alakaya M; Erdoğan S; Arslanköylü AE; Özgür D; Otağ ZF
Mikrobiyol Bul; 2021 Oct; 55(4):580-591. PubMed ID: 34666657
[TBL] [Abstract][Full Text] [Related]
23. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study.
Hermsen ED; Zapapas MK; Maiefski M; Rupp ME; Freifeld AG; Kalil AC
Crit Care; 2011 Aug; 15(4):R198. PubMed ID: 21846332
[TBL] [Abstract][Full Text] [Related]
24. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
[TBL] [Abstract][Full Text] [Related]
25. Antifungal susceptibility, species distribution and risk factors associated with mortality of invasive candidiasis in children in Turkey: A six-year retrospective, single-centre study.
Yakut N; Kepenekli E; Ergenc Z; Baran E; Cerikcioglu N
J Mycol Med; 2021 Mar; 31(1):101082. PubMed ID: 33249314
[TBL] [Abstract][Full Text] [Related]
26. Candida infections in paediatrics: Results from a prospective single-centre study in a tertiary care children's hospital.
Mesini A; Bandettini R; Caviglia I; Fioredda F; Amoroso L; Faraci M; Mattioli G; Piaggio G; Risso FM; Moscatelli A; Loy A; Castagnola E
Mycoses; 2017 Feb; 60(2):118-123. PubMed ID: 27681940
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study.
Aguilar G; Delgado C; Corrales I; Izquierdo A; Gracia E; Moreno T; Romero E; Ferrando C; Carbonell JA; Borrás R; Navarro D; Belda FJ
BMC Res Notes; 2015 Sep; 8():491. PubMed ID: 26415526
[TBL] [Abstract][Full Text] [Related]
28. Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.
Zeng ZR; Tian G; Ding YH; Yang K; Liu JB; Deng J
BMC Infect Dis; 2019 Nov; 19(1):939. PubMed ID: 31699043
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiological profile and sensitivity pattern of isolates causing invasive fungal infection vs. colonizing isolates in non-neutropenic critically ill patients].
Serrano R; Gimeno A; Plumed L; Pemán J; Alvarez B; Plazas J; Caturla J
Rev Iberoam Micol; 2013 Jan; 30(1):14-20. PubMed ID: 22749973
[TBL] [Abstract][Full Text] [Related]
31. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
32. [Épico project: Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Grupo Proyecto Épico].
Zaragoza R; Llinares P; Maseda E; Ferrer R; Rodríguez A;
Rev Iberoam Micol; 2013; 30(3 Suppl 1):135-49. PubMed ID: 23764554
[TBL] [Abstract][Full Text] [Related]
33. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.
Li F; Wu L; Cao B; Zhang Y; Li X; Liu Y
BMC Infect Dis; 2013 Jul; 13():353. PubMed ID: 23899244
[TBL] [Abstract][Full Text] [Related]
35. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
Xin H; Rosario-Colon JA; Eberle K
mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
[TBL] [Abstract][Full Text] [Related]
36.
Wang B; He X; Lu F; Li Y; Wang Y; Zhang M; Huang Y; Xia J
Front Public Health; 2021; 9():779590. PubMed ID: 34858938
[No Abstract] [Full Text] [Related]
37. Persistently positive cultures and outcome in invasive neonatal candidiasis.
Chapman RL; Faix RG
Pediatr Infect Dis J; 2000 Sep; 19(9):822-7. PubMed ID: 11001103
[TBL] [Abstract][Full Text] [Related]
38. Invasive candidiasis.
Lass-Flörl C; Kanj SS; Govender NP; Thompson GR; Ostrosky-Zeichner L; Govrins MA
Nat Rev Dis Primers; 2024 Mar; 10(1):20. PubMed ID: 38514673
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
